
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Nitrous Oxide
Therapeutic Area : Undisclosed
Study Phase : Phase II/ Phase III
Recipient : Boston Children's Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Nitrous Oxide for Pain Management During IUD Insertion in Nulliparous Adolescent Women
Details : Nitrous Oxide is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Long-Acting Reversible Contraception.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 13, 2019
Lead Product(s) : Nitrous Oxide
Therapeutic Area : Undisclosed
Highest Development Status : Phase II/ Phase III
Recipient : Boston Children's Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
